Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia

Completed · Not applicable

Conditions studied: Cystic Fibrosis

In brief

Four methods are routinely used to monitor CO2 in patients. End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia. CO2 is also monitored in other healthcare settings transcutaneously (TCO2), via finger stick capillary CO2 (CapCO2), and arterial blood gas (ABG). The purpose of this study is to perform all four measurements simultaneously during general anesthesia to identify which measure provides the most accurate data with the least amount of patient risk.

Key facts

Study ID

NCT03734822

Run by

Nationwide Children's Hospital

People needed

47

Starts

2016-03-10

Expected to finish

2017-12-20

Last updated by the study team

2019-03-14

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a confirmed diagnosis of cystic fibrosis (positive sweat chloride value ≥ 60 mEq/L) and/or genotype with two identifiable mutations consistent with CF, accompanied by one or more clinical features consistent with the CF phenotype)
• Hemodynamically stable undergoing general anesthesia for a scheduled procedure

You may not qualify if…

• Patients not diagnosed with CF
• CF patients undergoing anesthesia for emergency procedures

Where it is running

• Nationwide Children's Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.